BNT162B1

BioNTech and Pfizer's COVID-19 vaccine shows potential in human trial

The drug is one of 17 being tested on humans in a frantic global race to find a vaccine the world is counting on to end a pandemic that has infected 10.5 million people and killed more than half a million so far. No COVID-19 vaccine has yet been approved for commercial use.